LYMPHOKINE ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY

被引：0
|
作者：
EGGERMONT, AMM [1 ]
SUGARBAKER, PH [1 ]
机构：
[1] NCI,BETHESDA,MD 20892
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [21] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER (LAK) CELL THERAPY
    ISHIMITSU, T
    IWASAKI, K
    TORISU, M
    FASEB JOURNAL, 1992, 6 (04): : A1152 - A1152
  • [22] INTRAPERITONEAL LYMPHOKINE-ACTIVATED KILLER-CELL AND INTERLEUKIN-2 THERAPY FOR MALIGNANCIES LIMITED TO THE PERITONEAL-CAVITY
    STEIS, RG
    URBA, WJ
    VANDERMOLEN, LA
    BOOKMAN, MA
    SMITH, JW
    CLARK, JW
    MILLER, RL
    CRUM, ED
    BECKNER, SK
    MCKNIGHT, JE
    OZOLS, RF
    STEVENSON, HC
    YOUNG, RC
    LONGO, DL
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) : 1618 - 1629
  • [23] PREPARATIVE CYTOREDUCTIVE SURGERY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS LYMPHOKINE ACTIVATED KILLER-CELLS
    ROBERTSON, CN
    LINEHAN, WM
    PASS, HI
    GOMELLA, LG
    HAAS, GP
    BERMAN, A
    MERINO, M
    ROSENBERG, SA
    JOURNAL OF UROLOGY, 1990, 144 (03): : 614 - 618
  • [24] ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    ONISHI, S
    SAIBARA, T
    FUJIKAWA, M
    SAKAEDA, H
    MATSUURA, Y
    MATSUNAGA, Y
    YAMAMOTO, Y
    HEPATOLOGY, 1989, 10 (03) : 349 - 353
  • [25] Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors
    Sankhla, SK
    Nadkarni, JS
    Bhagwati, SN
    JOURNAL OF NEURO-ONCOLOGY, 1996, 27 (02) : 133 - 140
  • [26] ADMINISTRATION OF SLOWLY RELEASED RECOMBINANT INTERLEUKIN-2 - AUGMENTATION OF THE EFFICACY OF ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    NISHIMURA, T
    UCHIYAMA, Y
    YAGI, H
    HASHIMOTO, Y
    JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 91 (01) : 21 - 27
  • [27] ADOPTIVE IMMUNOTHERAPY OF HUMAN CANCER USING LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    SCHOOF, DD
    GRAMOLINI, BA
    DAVIDSON, DL
    MASSARO, AF
    WILSON, RE
    EBERLEIN, TJ
    CANCER RESEARCH, 1988, 48 (17) : 5007 - 5010
  • [28] INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER-CELLS
    HAMBLIN, TJ
    TRANSFUSION SCIENCE, 1991, 12 (1-2): : 35 - 42
  • [29] INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY OF NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    BERNSTEIN, ZP
    VAICKUS, L
    FRIEDMAN, N
    GOLDROSEN, MH
    WATANABE, H
    RAHMAN, R
    ARBUCK, SG
    SWEENEY, J
    VESPER, D
    HENDERSON, ED
    ZEFFREN, J
    DENNIN, RA
    LEVITT, D
    FOON, KA
    JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02): : 141 - 146
  • [30] THE INFLUENCE OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER-CELL INFUSIONS ON THE TOXICITY AND ANTITUMOR EFFECT OF REPETITIVE CYCLES OF INTERLEUKIN-2
    ALBERTINI, MR
    SOSMAN, JA
    HANK, JA
    MOORE, KH
    BORCHERT, A
    SCHELL, K
    KOHLER, PC
    BECHHOFER, R
    STORER, B
    SONDEL, PM
    CANCER, 1990, 66 (12) : 2457 - 2464
12345